{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:54:28Z","timestamp":1777582468006,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070035"],"award-info":[{"award-number":["82070035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370043"],"award-info":[{"award-number":["82370043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.imbio.2024.152824","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T19:36:15Z","timestamp":1718220975000},"page":"152824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Increased inhibitory surface marker PD-1 expression in CD4+T cells and Th2+T cells in allergen-specific immunotherapy"],"prefix":"10.1016","volume":"229","author":[{"given":"Xueyan","family":"Jie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongju","family":"Da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianghao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haicheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2024.152824_b0005","first-page":"13","article-title":"HLA and Non-HLA gene polymorphisms in autoimmune hepatitis patients of North Indian adults","author":"Ahuja","year":"2023","journal-title":"Front. Immunol."},{"issue":"S25","key":"10.1016\/j.imbio.2024.152824_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pai.13189","article-title":"Allergen immunotherapy in children user\u2019s guide","volume":"31","author":"Alvaro-Lozano","year":"2020","journal-title":"Pediatr. Allergy Immunol."},{"issue":"7","key":"10.1016\/j.imbio.2024.152824_b0015","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ccell.2022.06.001","article-title":"Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence","volume":"40","author":"Belk","year":"2022","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.imbio.2024.152824_b0020","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental relationships of four exhausted CD8 T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.imbio.2024.152824_b0025","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.4049\/jimmunol.1100714","article-title":"Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3","volume":"187","author":"Bettini","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2024.152824_b0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0091-6749(98)70271-4","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper","volume":"102","author":"Bousquet","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2024.152824_b0035","article-title":"Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma","volume":"9","author":"Bousquet","year":"2019","journal-title":"Clin. Transl. Allergy"},{"key":"10.1016\/j.imbio.2024.152824_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102283","article-title":"Immune checkpoint receptors in autoimmunity","volume":"80","author":"Burke","year":"2023","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2024.152824_b0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56336-8","article-title":"Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB\/c mice reduce parasite load","volume":"9","author":"da Fonseca-Martins","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imbio.2024.152824_b0050","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fped.2019.00246","article-title":"Epidemiology of asthma in children and adults","volume":"7","author":"Dharmage","year":"2019","journal-title":"Front. Pediatr."},{"issue":"2","key":"10.1016\/j.imbio.2024.152824_b0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/25785826.2022.2137967","article-title":"The association between PD-1 gene polymorphisms and susceptibility to multiple sclerosis","volume":"46","author":"Hassani","year":"2022","journal-title":"Immunol. Med."},{"key":"10.1016\/j.imbio.2024.152824_b0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molimm.2022.02.005","article-title":"Expression of Id3 represses exhaustion of anti-tumor CD8 T cells in liver cancer","volume":"144","author":"Jin","year":"2022","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2024.152824_b0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cei.13577","article-title":"Exhausted T cells in systemic lupus erythematosus patients in long-standing remission","volume":"204","author":"Lima","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2024.152824_b0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science (New York, N.Y.)"},{"issue":"8","key":"10.1016\/j.imbio.2024.152824_b0075","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2016-04-712612","article-title":"CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency","volume":"128","author":"Lo","year":"2016","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.imbio.2024.152824_b0080","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1158\/1078-0432.CCR-21-0206","article-title":"CD4 T-cell exhaustion: does it exist and what are its roles in cancer?","volume":"27","author":"Miggelbrink","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"7912","key":"10.1016\/j.imbio.2024.152824_b0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-022-04713-1","article-title":"Single-cell eQTL models reveal dynamic T cell state dependence of disease loci","volume":"606","author":"Nathan","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.imbio.2024.152824_b0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26471-9","article-title":"Interferon-gamma drives programmed death-ligand 1 expression on islet \u03b2 cells to limit T cell function during autoimmune diabetes","volume":"8","author":"Osum","year":"2018","journal-title":"Sci. Rep."},{"issue":"6316","key":"10.1016\/j.imbio.2024.152824_b0095","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.imbio.2024.152824_b0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2018.08.003","article-title":"T cell exhaustion implications during transplantation","volume":"202","author":"Shahbazi","year":"2018","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.imbio.2024.152824_b0105","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2022.01.016","article-title":"Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma","volume":"149","author":"Shamji","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2024.152824_b0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/ACI.0000000000000216","article-title":"Effect of allergen-specific immunotherapy on CD4+ T cells","volume":"15","author":"Wambre","year":"2015","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.imbio.2024.152824_b0115","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1111\/all.14896","article-title":"An exhausted phenotype of TH2 cells is primed by allergen exposure, but not reinforced by allergen-specific immunotherapy","volume":"76","author":"Wang","year":"2021","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.imbio.2024.152824_b0120","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"19","key":"10.1016\/j.imbio.2024.152824_b0125","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1158\/1078-0432.CCR-20-0558","article-title":"TIGIT expression is associated with T-cell suppression and exhaustion and predicts clinical outcome and anti\u2013PD-1 response in follicular lymphoma","volume":"26","author":"Yang","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.imbio.2024.152824_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-01987-7","article-title":"Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer","volume":"40","author":"Zhang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298524000421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298524000421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T22:20:17Z","timestamp":1718922017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298524000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0171298524000421"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2024.152824","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased inhibitory surface marker PD-1 expression in CD4+T cells and Th2+T cells in allergen-specific immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2024.152824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152824"}}